Perceptive Advisors LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Perceptive Advisors LLC disclosed 92 US equity positions worth $5.1bn in its Q1 2026 13F filing. The largest position was PRAX at 13.0% of the reported book, followed by CELC and ASND.
What did Perceptive Advisors LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 13.0% | $656.0m | 2,035,986 | – | |
| 2 | CELC CELCUITY INC | Healthcare | 7.1% | $356.9m | 3,127,200 | – | |
| 3 | ASND ASCENDIS PHARMA A/S | Healthcare | 6.9% | $350.3m | 1,531,421 | – | |
| 4 | ROIV ROIVANT SCIENCES LTD | Healthcare | 4.5% | $229.5m | 8,285,461 | – | |
| 5 | CNTA CENTESSA PHARMACEUTICALS PLC | 4.1% | $208.9m | 5,258,903 | – | ||
| 6 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 4.1% | $206.4m | 2,373,795 | – | |
| 7 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 3.8% | $190.8m | 3,783,225 | – | |
| 8 | NUVALENT INC | 3.2% | $161.9m | 1,580,505 | – | ||
| 9 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 2.8% | $139.4m | 4,423,974 | – | |
| 10 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.6% | $129.7m | 1,230,879 | – | |
| 11 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.6% | $129.7m | 1,540,384 | – | |
| 12 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.4% | $123.1m | 4,142,551 | – | |
| 13 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 2.3% | $115.2m | 8,284,882 | – | |
| 14 | IMTX IMMATICS N.V | Healthcare | 2.0% | $102.2m | 10,383,456 | – | |
| 15 | RLAY RELAY THERAPEUTICS INC | Healthcare | 1.9% | $97.0m | 9,751,141 | – | |
| 16 | INBX INHIBRX BIOSCIENCES INC | Healthcare | 1.9% | $97.0m | 1,442,707 | – | |
| 17 | MGTX MEIRAGTX HLDGS PLC | Healthcare | 1.8% | $89.3m | 10,326,103 | – | |
| 18 | ZYME ZYMEWORKS INC | Healthcare | 1.7% | $87.9m | 3,510,078 | – | |
| 19 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.7% | $85.7m | 11,906,646 | – | |
| 20 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.7% | $84.6m | 4,668,839 | – | |
| 21 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.4% | $70.8m | 7,434,033 | – | |
| 22 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.4% | $68.4m | 1,395,501 | – | |
| 23 | AORT ARTIVION INC | Healthcare | 1.2% | $60.0m | 1,637,290 | – | |
| 24 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.1% | $57.5m | 3,710,877 | – | |
| 25 | NAUT NAUTILUS BIOTECHNOLOGY INC | 1.0% | $48.9m | 12,594,211 | – | ||
| 26 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 0.9% | $47.5m | 10,098,824 | – | |
| 27 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.9% | $45.2m | 2,009,893 | – | |
| 28 | ENGENE HOLDINGS INC | 0.8% | $39.7m | 5,827,506 | – | ||
| 29 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $39.7m | 1,597,383 | – | |
| 30 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.8% | $39.4m | 85,419 | – | |
| 31 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.7% | $37.8m | 504,000 | – | |
| 32 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.7% | $37.6m | 1,755,799 | – | ||
| 33 | ABVX ABIVAX SA | Healthcare | 0.7% | $36.6m | 328,884 | – | |
| 34 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 0.7% | $33.5m | 2,292,441 | – | |
| 35 | RGEN REPLIGEN CORP | Healthcare | 0.7% | $33.1m | 280,541 | – | |
| 36 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 0.6% | $32.1m | 170,000 | – | |
| 37 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 0.6% | $31.7m | 1,223,000 | – | |
| 38 | XFOR X4 PHARMACEUTICALS INC | 0.5% | $27.8m | 6,737,648 | – | ||
| 39 | GH GUARDANT HEALTH INC | Healthcare | 0.5% | $27.7m | 300,000 | – | |
| 40 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.5% | $27.5m | 377,544 | – | |
| 41 | IVVD INVIVYD INC | Healthcare | 0.5% | $27.1m | 20,859,303 | – | |
| 42 | SION SIONNA THERAPEUTICS INC | Healthcare | 0.5% | $26.4m | 658,439 | – | |
| 43 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 0.5% | $25.3m | 149,950 | – | |
| 44 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.5% | $25.1m | 258,600 | – | |
| 45 | SABS SAB BIOTHERAPEUTICS INC | 0.5% | $24.6m | 6,431,743 | – | ||
| 46 | BLTE BELITE BIO INC | Healthcare | 0.5% | $24.2m | 151,979 | – | |
| 47 | TENX TENAX THERAPEUTICS INC | 0.5% | $23.2m | 1,447,782 | – | ||
| 48 | AXGN AXOGEN INC | Healthcare | 0.5% | $23.1m | 697,312 | – | |
| 49 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.5% | $22.9m | 1,170,829 | – | |
| 50 | OBIO ORCHESTRA BIOMED HLDGS INC | 0.4% | $21.4m | 5,037,906 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.